Aronica, S. M., and B. S. Katzenellenbogen. 1991. Progesterone
receptor regulation in uterine cells: stimulation by estrogen,
cyclic adenosine 3',5'-monophosphate, and insulin-like growth
factor I and suppression by antiestrogens and protein kinase
inhibitors. Endrocinology 128:2045-2052.
Berkenstam, A., H. Glaumann, M. Martin, J. A. Gustafsson, and
G. Norstedt. 1989. Hormonal regulation of estrogen receptor
messenger ribonucleic acid in T47Dco and MCF-7 breast cancer
cells. Mol. Endocrinol. 3:22-28.
Berry, M., D. Metzger, and P. Chambon. 1990. Role of the two
activating domains of the oestrogen receptor in the cell-type and
promoter-context dependent agonistic activity of the antioestrogen 4-hydroxytamoxifen. EMBO J. 9:2811-2818.
Brown, M., and P. Sharp. 1990. Human estrogen receptor forms
multiple-DNA complexes. J. Biol. Chem. 265:11238-11243.
Carson-Jurica, M. A., W. T. Schrader, and B. W. O'Maliey.
1990. Steroid receptor family: structure and function. Endocr.
Rev. 11:201-220.
Chang, T.-C., A. M. Nardulli, D. Lew, and D. J. Shapiro. 1992.
The role of estrogen response elements in expression of the
Xenopus laevis vitellogenin Bi gene. Mol. Endocrinol. 6:346-354.
Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol.
7:2745-2752.
Clarke, R., N. Brunner, B. S. Katzenellenbogen, E. W. Thompson, M. J. Norman, C. Koppi, S. Paik, M. E. Lippman, and R. B.
Dickson. 1989. Progression of human breast cancer cells from
hormone-dependent to hormone-independent growth both in
vitro and in vivo. Proc. Natl. Acad. Sci. USA 86:3649-3653.
Elliston, J. F., S. Y. Tsai, B. W. O'Malley, and M.-J. Tsai. 1990.
Superactive estrogen receptors. J. Biol. Chem. 265:11517-11521.
Fawell, S. E., J. A. Lees, R. White, and M. G. Parker. 1990.
Characterization and colocalization of steroid binding and
dimerization activities in the mouse estrogen receptor. Cell
60:953-962.
Fawell, S. E., R. White, S. Hoare, M. Sydenham, M. Page, and
M. G. Parker. 1990. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be
mediated by impaired receptor dimerization. Proc. Nati. Acad.
Sci. USA 87:6883-6887.
Gibson, M. K., L. A. Nemmers, W. C. Beckman, Jr., V. L.
Davis, S. W. Curtis, and K. S. Korach. 1991. The mechanism of
ICI 164,384 antiestrogenicity involves rapid loss of estrogen
receptor in uterine tissue. Endocrinology 129:2000-2010.
Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982.
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
Greene, G. L., N. B. Sobel, W. J. King, and E. V. Jensen. 1984.
Immunochemical studies of estrogen receptors. J. Steroid Biochem. 20:51-56.
Herbomel, P., B. Bourachot, and M. Yaniv. 1984. Two distinct
enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39:653-662.
Hu, M. C.-T., and N. Davidson. 1987. The inducible lac operator-repressor system is functional in mammalian cells. Cell
48:555-566.
King, W. J., and G. L. Greene. 1984. Monoclonal antibodies
localize estrogen receptor in the nuclei of target cells. Nature
(London) 307:745-749.
Kumar, V. J., and P. Chambon. 1988. The estrogen receptor
binds to its responsive element as a ligand-induced homodimer.
Cell 55:145-156.
Laemmli, U. K. 1970. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature (London)
227:680-685.
Lees, J. A., S. E. Fawell, and M. G. Parker. 1989. Identification
of two transactivation domains in the mouse oestrogen receptor.
Nucleic Acids Res. 17:5477-5487.
Martinez, E., and W. Wahli. 1989. Cooperative binding of
estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent en-
